|
市場調査レポート
商品コード
1276567
皮膚消毒薬の世界市場規模、シェア、産業動向分析レポート:タイプ別、流通チャネル別、形態別、地域別、展望と予測、2023~2029年Global Skin Antiseptic Market Size, Share & Industry Trends Analysis Report By Type (Alcohol, Chlorhexidine, Iodine), By Distribution Channel, By Form (Solutions, Swab Sticks, Cream), By Regional Outlook and Forecast, 2023 - 2029 |
||||||
皮膚消毒薬の世界市場規模、シェア、産業動向分析レポート:タイプ別、流通チャネル別、形態別、地域別、展望と予測、2023~2029年 |
出版日: 2023年04月28日
発行: KBV Research
ページ情報: 英文 209 Pages
納期: 即納可能
|
皮膚消毒薬市場規模は2029年までに25億米ドルに達し、予測期間中にCAGR7.4%の市場成長率で上昇すると予測されています。
病院内感染の発生率の増加が、皮膚消毒薬の需要を促進する主な要因となっています。ヘルスケアセンターの患者は、これらの病気の原因となる細菌、ウイルス、その他の細菌を拾う可能性があります。HAIは、軽症から重症まで様々な病気を引き起こし、時には死に至ることもあります。そのため、ヘルスケア施設では、HAIを予防するために、皮膚消毒薬を含む厳格な衛生基準を守る必要があります。さらに、皮膚消毒薬は、手術やその他の医療処置のような侵襲的な処置の後の感染リスクを低下させるためにも重要です。
さらに、医療費の高騰により、防腐剤市場の成長率が世界的に高まっていることも確認されています。ヘルスケア分野の拡大により、治療水準の向上と感染率の低下がより重視されるようになりました。その結果、防腐剤、特に皮膚消毒薬の需要が増加しています。
COVID-19の影響分析
皮膚消毒薬は医療施設以外でも使用されるようになり、市場拡大に好影響を与えています。皮膚の消毒に使われる皮膚消毒薬は、アルコール成分の割合が高い手指消毒剤が主流です。COVID-19ウイルスだけでなく、ほとんどの細菌やウイルスを除去することができます。また、手指消毒剤だけでなく、アルコール配合のウェットティッシュやスプレーなどの皮膚消毒薬も利用されています。その結果、パンデミックは市場拡大にプラスに寄与しました。
市場成長要因
交通事故の増加
交通事故による死亡者のうち、歩行者、自転車、オートバイの利用者は半数以上を占めています。また、中低所得国の自動車保有台数は世界の約60%であるにもかかわらず、交通事故死者数の93%を占めています。このような交通事故による負傷者の増加を受け、ヘルスケア関係者は、効果的でタイムリーなケアを提供しなければならないというプレッシャーにさらされています。交通事故の増加に伴い、傷の治療などに使用される皮膚消毒薬のニーズも高まっています。
HAIの発生が増加する
老人人口の増加、糖尿病、心臓、がん、肥満、呼吸器疾患などの慢性疾患の症例の増加が、HAIの増加の主な原因となっています。長年にわたり、世界中で行われる外科手術の数は著しく増加しています。外科手術の割合が増えることで、さまざまな外科器具や医療機器に対する需要が高まっています。このため、病院内感染の発生率が高まることが予想されます。HAIの市場開拓を避けるため、皮膚消毒薬の市場は拡大すると予想されています。
市場抑制要因
皮膚消毒薬の滅菌に関する懸念
製造工程で本質的な汚染が発生します。皮膚消毒薬の多くは水性であるため、製品を滅菌するか包装後に滅菌しない限り、この問題はすべての水性メーカーに影響します。水系から微生物を含むバイオフィルムを除去することは困難であり、不可能であるため、これらの微生物の一部は、製造中に間違いなく最終製品に感染します。その対策としては、「滅菌する」というのが一般的です。今後、皮膚消毒薬の問題が市場拡大の妨げになる可能性があります。
タイプの展望
皮膚消毒薬市場は、タイプ別に、アルコール、クロルヘキシジン、ヨウ素、その他に分類されます。2022年の皮膚消毒薬市場では、クロルヘキシジンセグメントが大きな収益シェアを獲得しました。皮膚感染症は、局所的な防腐剤であるクロルヘキシジンで治療されます。これは、皮膚にある菌や細菌を除去することで作動します。そのため、腫れ物、にきび、湿疹などの皮膚疾患は、この種の治療薬で頻繁に治療されます。さらに、この物質は、皮膚の除菌と洗浄に利用されます。また、皮膚の炎症を防ぐのにも役立ちます。
販売チャネルの展望
流通チャネル別に見ると、皮膚消毒薬市場は、病院薬局、オンラインプロバイダー、ドラッグストア&小売薬局に二分されます。2022年には、ドラッグストア&小売薬局セグメントが皮膚消毒薬市場を独占し、最大の収益シェアを獲得しました。これは主に、外来治療に対する需要の高まりと、感染管理の意義に対する理解の高まりによるものです。さらに、これらの店舗で皮膚消毒薬を簡単に入手できることも、このセグメントの市場拡大を支える要因の1つとなっています。
形態の展望
皮膚消毒薬市場は、形態別にソリューション、クリーム、スワブスティック、その他に分類されます。2022年の皮膚消毒薬市場では、クリーム分野がかなりの収益シェアを占めています。軽度の火傷ややけど、切り傷や擦り傷、ひび割れ、日焼け、乾燥、おむつかぶれ、虫刺され、シミ、吹き出物などは、消毒クリームで治療することができ、感染を防ぎながら傷を和らげ治すことができます。このように、クリームは簡単に手に入ることが、成長を促進する重要な要素となっています。
地域の展望
地域別に見ると、皮膚消毒薬市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカの4地域で分析されています。アジア太平洋地域は、2022年の皮膚消毒薬市場において大きな収益シェアを獲得しました。主な市場促進要因の1つは、官民両部門におけるヘルスケア支出の増加です。このシナリオの結果、市場は増加すると考えられ、複数の大手企業や地元企業を惹きつけると予想されます。
List of Figures
The Global Skin Antiseptic Market size is expected to reach $2.5 billion by 2029, rising at a market growth of 7.4% CAGR during the forecast period.
Skin antiseptics are compounds applied to the skin surface to eradicate or prevent the growth of germs. These substances are applied to the skin before surgical procedures to prevent infections. Skin antiseptics are crucial for maintaining a sterile environment when performing surgery or other invasive medical operations. The main goal of employing skin antiseptics is to lessen the number of bacteria on the skin's surface since these organisms might cause infections if they enter the body through a cut or other surgical invasion.
The danger of infections and the consequences they cause can be drastically decreased by healthcare professionals utilizing skin antiseptics. Also, there are numerous kinds of skin antiseptics available, including liquids, sprays, gels, and wipes. A wide variety of bacteria can be defeated by the active chemicals they contain. Povidone-iodine, chlorhexidine, and alcohol are the most often utilized active components in skin antiseptics.
The increased incidence of hospital-acquired infections is the primary factor driving the demand for skin antiseptics. Patients in a healthcare center can pick up bacteria, viruses, and other germs that cause these ailments. HAIs can result in various illnesses, from minor to serious, and can occasionally even result in death. Therefore, healthcare institutions must uphold strict hygiene standards, including skin antiseptics, to prevent HAIs. Skin antiseptics are furthermore crucial for lowering the risk of infection after intrusive treatments like surgeries and other medical procedures.
Moreover, a faster rate of growth in the antiseptic market has been observed globally due to rising healthcare costs. A greater emphasis is being placed on raising the standard of treatment and lowering infection rates as a result of the expanding healthcare sector. As a result, there is a rise in the demand for antiseptics, notably skin antiseptics.
COVID-19 Impact Analysis
The use of skin antiseptics extended outside of medical facilities, which had a favorable effect on the market expansion. The most popular skin antiseptics for skin disinfection are hand sanitizers having a significant proportion of alcohol content. They are capable of eliminating the COVID-19 virus as well as the majority of bacteria and viruses. Other skin antiseptics, like wipes and sprays with alcohol as an ingredient, are utilized in addition to hand sanitizers. Consequently, the pandemic contributed positively to market expansion.
Market Growth Factors
Rise in occurrence of road accidents
Pedestrians, bicyclists, and motorcyclists make up more than half of all road traffic fatalities. Despite the fact that low- and middle-income nations have about 60% of the world's vehicles, they account for 93% of all traffic deaths. Given the rise in traffic-related injuries, healthcare practitioners are under a lot of pressure to deliver effective and timely care. The need for skin antiseptics for wound care and other uses will increase along with traffic accidents.
Growing occurrence of HAI
The increase in the geriatric population, and the growth in cases of chronic conditions like diabetes, heart, cancer, obesity, and respiratory ailments are the leading causes of the rise in HAI. Over the years, the number of surgical operations carried out globally has risen significantly. The growing percentage of surgical operations has increased the demand for various surgical apparatus and medical devices. This is anticipated to increase the rate of hospital-acquired infections. In order to avoid the development of HAI, the market for cutaneous antiseptics is anticipated to expand.
Market Restraining Factors
Concerns regarding the sterilization of skin antiseptics
Intrinsic contamination happens throughout the manufacturing process. Since most skin antiseptics are water-based, this problem will affect all water-based manufacturers unless the product can be sterilized or is sterilized after packaging. Due to the difficulty or impossibility of removing biofilms containing microorganisms from water systems, some of these organisms will undoubtedly infect the finished product during production. The main remedy for this would seem straightforward: sterilize the finished item. Over the projected time, the problem with skin antiseptics may impede market expansion.
Type Outlook
Based on type, the skin antiseptic market is segmented into alcohol, chlorhexidine, iodine and others. The chlorhexidine segment acquired a significant revenue share in the skin antiseptic market in 2022. Skin infections are treated with chlorhexidine, a topical antiseptic. It operates by eliminating skin-based fungi and germs. Therefore, skin problems like boils, acne, and eczema are frequently treated with this kind of treatment. Moreover, this substance is utilized to sanitize and clean the skin. Also, it helps to avoid skin inflammation.
Distribution Channel Outlook
By distribution channel, the skin antiseptic market is bifurcated into hospital pharmacies, online providers, drug stores & retail pharmacies. In 2022, the drug stores & retail pharmacies segment dominated the skin antiseptic market with the maximum revenue share. It is primarily driven by the rising demand for outpatient treatments and the growing understanding of the significance of infection control. Additionally, the easy accessibility of skin antiseptics from these stores is one of the factors supporting market expansion in this segment.
Form Outlook
On the basis of form, the skin antiseptic market is fragmented into solutions, cream, swab sticks, and others. The cream segment covered a considerable revenue share in the skin antiseptic market in 2022. Minor burns and scalds, cuts & grazes, chapped skin, tiny areas of sunburn, dryness, diaper rash, bug bites, spots, and pimples can all be treated with antiseptic cream also soothes and cures wounds while preventing infection. The key component promoting the growth is the creams' simple availability.
Regional Outlook
Region wise, the skin antiseptic market is analyzed across North America, Europe, Asia Pacific and LAMEA. The Asia Pacific region garnered a significant revenue share in the skin antiseptic market in 2022. One of the main market drivers is the rise in healthcare spending in both the public and private sectors. The market is likely to increase as a result of this scenario, which is expected to attract several major and local businesses.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include XTTRIUM Laboratories, Sirmaxo Chemicals Private Limited, SCHULKE & Mayr GmbH, MOLNLYCKE Health Care (Investor AB), Cardinal Health, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, 3M Company, PDI Healthcare, Inc. and Ecolab, Inc.
Strategies deployed in Skin Antiseptic Market
Apr-2023: 3M Health Care launched the new FDA-approved 3M SoluPrep S Sterile Antiseptic Solution chlorhexidine gluconate (2% w/v) and isopropyl alcohol (70% v/v) Patient Preoperative Skin Preparation. The product has been shown to have fast-acting, broad-spectrum antibacterial action (in vitro; clinical significance unknown) and to persist in healthy human volunteers for at least 96 hours post-prep. 3M SoluPrep S Sterile Antiseptic Solution offers the efficacy healthcare professionals can rely on with the same active ingredients as the industry leader and additional benefits to help patients be protected. It is ideal for operating room nurses, doctors, and infection control professionals who want to prepare patient skin safely, effectively, and confidently before surgery to get rid of microorganisms on the skin that could potentially cause skin infections.
Jul-2022: Schulke Group took over Wet Wipes A/S, a market leader in surface wipes in the Scandinavian healthcare market. The acquisition complemented the company's product portfolio and would help in further expansion to the Scandinavian market.
Mar-2022: PDI Healthcare announced the dual launch of Sani-24® Germicidal Disposable Wipe, Sani-HyPerCide® Germicidal Spray, and Sani-HyPerCide® Germicidal Disposable Wipe, the novel, and innovative disinfectants. These products would help professionals in infection prevention in the fight against COVID-19 and healthcare-associated infections.
Mar-2022: Cardinal Health introduced the first surgical incise drape utilizing industry-leading antiseptic Chlorhexidine Gluconate (CHG). The drape has patented BeneHold CHG adhesive technology from Avery Dennison, which helps lower the risk of surgical site contamination with microorganisms that are frequently linked to surgical site infections (SSIs). The incise film offers a sterile surface to create a barrier to contamination and is sturdy, conformable, and breathable. Using CHG's antimicrobial characteristics in the surgical drape's adhesive is a novel strategy that aims to improve patient care by further lowering the risk of microbial contamination. CHG is a trusted topical antiseptic for surgical patient skin preparation.
Jan-2022: B. Braun opened a state-of-art Haemodialysis Concentrate Factory in the Thanh Oai Industrial Complex in Hanoi, Vietnam. With an initial investment of USD 5 million and a construction footprint of roughly 4000m2, the Haemodialysis Concentrate Factory enabled B. Braun Vietnam to supply the domestic and international markets with more than 2.5 million 10-litre canisters of hemodialysis each year. Additionally, it will make it possible for B. Braun Vietnam to continue serving the market and contribute to the daily protection and enhancement of the health of thousands of patients in Vietnam and all over the world.
Jun-2021: Schulke & Mayr GmbH announced an exclusive distribution agreement with Bactiguard for its wound care solutions' range to German hospitals. The agreement enabled Schulke to add Bactiguard's hypochlorous acid-based portfolio to its extensive line of antibacterial and wound care products.
Jul-2020: BD introduced the BD PurPrep patient preoperative skin preparation with a sterile solution. This solution is the first and single fully sterile povidone-iodine plus isopropyl alcohol single-use antiseptic skin preparation commercially accessible in the United States.
Market Segments covered in the Report:
By Type
By Distribution Channel
By Form
By Geography
Companies Profiled
Unique Offerings from KBV Research